Eu Ivdd Eu Ivd General On The Market 🇨🇳 China

LIPOPROTEIN ( A )

Devices (same UDI-DI)
1
Certificates
0
Countries
6
Notified Bodies
0

Basic Information

Primary DI
06975225464156
Basic UDI-DI Code
B-06975225464156
Reference
DTSH060803C
Device Types
None provided
Regulation
Eu Ivdd
Classification
Eu Ivd General
Status
On The Market

Additional Description

"The kit is intended for in vitro quantitative determination of non-esterified fatty acid (NEFA) in human serum and is mainly used in the auxiliary diagnosis of hyperlipidemia, coronary heart disease, and atherosclerosis clinically. Free fatty acid, also called non-esterified fatty acid (NEFA), is an intermediate product and a sensitive indicator of fat metabolism in the body [1,2]. Studies have shown that NEFA level is generally higher in young and middle-aged hyperlipidemic populations than in normal groups[3]. Elevated serum NEFA level is the main cause of mitochondrial dysfunction and induced oxidative stress. This process mediates damage to vascular endothelial cells and thus promotes the occurrence and development of atherosclerosis and coronary heart disease (CHD)"

CND Nomenclature Codes

Code Description
W0102010405 LIPOPROTEIN ( A )

Available In Countries

🇧🇪 Belgium 🇩🇪 Germany 🇫🇷 France 🇮🇹 Italy 🇳🇱 Netherlands 🇸🇪 Sweden

Similar Devices

Other on-the-market devices with the same classification (Eu Ivd General) and regulation (EU IVDD).

View all